相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P. Nusinow et al.
CELL (2020)
Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis
Amirali B. Bukhari et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress
Lucy A. Young et al.
CANCER RESEARCH (2019)
The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers
Antonio Marzio et al.
MOLECULAR CELL (2019)
PIDD mediates the association of DNA-PKcs and ATR at stalled replication forks to facilitate the ATR signaling pathway
Yu-Fen Lin et al.
NUCLEIC ACIDS RESEARCH (2018)
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Panagiotis Kotsantis et al.
CANCER DISCOVERY (2018)
Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Juan Jin et al.
NEOPLASIA (2018)
High speed of fork progression induces DNA replication stress and genomic instability
Apolinar Maya-Mendoza et al.
NATURE (2018)
Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
James M. McFarland et al.
NATURE COMMUNICATIONS (2018)
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen et al.
CLINICAL CANCER RESEARCH (2018)
Directing the use of DDR kinase inhibitors in cancer treatment
Inger Brandsma et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
Stephanie A. Yazinski et al.
GENES & DEVELOPMENT (2017)
Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer
Triparna Sen et al.
CLINICAL CANCER RESEARCH (2017)
CImbinator: a web-based tool for drug synergy analysis in small- and large-scale datasets
Asmund Flobak et al.
BIOINFORMATICS (2017)
SynergyFinder: a web application for analyzing drug combination dose-response matrix data
Aleksandr Ianevski et al.
BIOINFORMATICS (2017)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
A Genome-wide CRISPR Screen Identifies CDC25A as a Determinant of Sensitivity to ATR Inhibitors
Sergio Ruiz et al.
MOLECULAR CELL (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Kumar Sanjiv et al.
CELL REPORTS (2016)
Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation
Sophia X. Pfister et al.
CANCER CELL (2015)
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways
Marieke Aarts et al.
MOLECULAR CANCER THERAPEUTICS (2015)
The Replication Checkpoint Prevents Two Types of Fork Collapse without Regulating Replisome Stability
Huzefa Dungrawala et al.
MOLECULAR CELL (2015)
Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
Remi Buisson et al.
MOLECULAR CELL (2015)
Exploiting replicative stress to treat cancer
Matthias Dobbelstein et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity
Anne Margriet Heijink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PTEN regulates DNA replication progression and stalled fork recovery
Jinxue He et al.
NATURE COMMUNICATIONS (2015)
DNA-PK phosphorylation of RPA32 Ser4/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe
Amanda K. Ashley et al.
DNA REPAIR (2014)
DNA-PK: A dynamic enzyme in a versatile DSB repair pathway
Anthony J. Davis et al.
DNA REPAIR (2014)
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
Ana Slipicevic et al.
GYNECOLOGIC ONCOLOGY (2014)
Ultrasensitive proteome analysis using paramagnetic bead technology
Christopher S. Hughes et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
HiRIEF LC-MSMS enables deep proteome coverage and unbiased proteogenomics
Rui M. M. Branca et al.
NATURE METHODS (2014)
DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response
Yu-Fen Lin et al.
NUCLEIC ACIDS RESEARCH (2014)
MS-GF plus makes progress towards a universal database search tool for proteomics
Sangtae Kim et al.
NATURE COMMUNICATIONS (2014)
ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA
Luis Ignacio Toledo et al.
CELL (2013)
Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation
Bridget T. Hughes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K
Joanne M. Munck et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication
Claus Storgaard Sorensen et al.
NUCLEIC ACIDS RESEARCH (2012)
Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway
Azadeh Arabi et al.
NATURE COMMUNICATIONS (2012)
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Marieke Aarts et al.
CANCER DISCOVERY (2012)
Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability
Naihan Xu et al.
JOURNAL OF ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
Luis I. Toledo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo
Florence Debacq-Chainiaux et al.
NATURE PROTOCOLS (2009)
Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
Elizabeth Iorns et al.
PLOS ONE (2009)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
An oncogene-induced DNA damage model for cancer development
Thanos D. Halazonetis et al.
SCIENCE (2008)
Living on a break: cellular senescence as a DNA-damage response
Fabrizio d'Adda di Fagagna
NATURE REVIEWS CANCER (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
Semi-supervised learning for peptide identification from shotgun proteomics datasets
Lukas Kall et al.
NATURE METHODS (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Lack of PTEN sequesters CHK1 and initiates genetic instability
J Puc et al.
CANCER CELL (2005)
分享论文
